For example, p-STAT3 expression was detected in 38% of oligodendroglioma patients (n = 16), 40% of anaplastic oligodendroglioma (AO) patients (n = 15), and 100% of WHO grade II MOA patients (n = 6). Here, STAT3 is linked to oligodendroglioma.